Hindustan Unilever Limited has approved the acquisition of the remaining 49% stake in Zywie Ventures Private Limited (OZiva) for a cash consideration of Rs 824 crore, while also deciding to divest its entire 19.8% holding in Nutritionalab Private Limited for Rs 307 crore.
According to the company’s disclosure dated February 12, 2026 , the Board approved the acquisition of the balance stake in Zywie, which will make OZiva and its wholly owned subsidiary Zenherb Labs Private Limited fully owned subsidiaries of HUL.
Details of OZiva acquisition
As per Annexure 1 of the filing (page 3 and 4) :
- Zywie Ventures reported turnover of Rs 257.67 crore in FY25.
- The company operates in the Health & Wellbeing segment, including vitamins, minerals, supplements, beauty and personal care, and protein products.
- HUL will acquire the remaining 49% stake for Rs 824 crore in cash.
- Post acquisition, HUL will hold 100% ownership of Zywie.
The transaction is expected to be completed by March 31, 2026, subject to customary closing conditions .
Sale of Nutritionalab stake
As disclosed in Annexure 2 (page 5) :
- Nutritionalab recorded revenue from operations of Rs 118.48 crore in FY25.
- HUL will sell its 19.8% stake to USV Private Limited for Rs 307 crore.
- The transaction does not fall under related party transactions.
- Completion is expected by March 31, 2026, subject to terms and conditions .
Strategic focus on Health & Wellbeing
In the press release (page 7) , HUL stated that OZiva scaled to approximately Rs 480 crore in 2025 with a growth of around 130% CAGR over the last two years. The company indicated that the move aligns with its strategy of focusing on “fewer, bigger bets” within its Health & Wellbeing portfolio.
Both transactions are subject to regulatory and contractual completion terms and are expected to close by March 2026.
